A citation-based method for searching scientific literature

Esther Conde, Ana Suárez-Gauthier, Amparo Benito, Pilar Garrido, Rosario García-Campelo, Michele Biscuola, Luis Paz-Ares, David Hardisson, Javier de Castro, M Carmen Camacho, Delvys Rodriguez-Abreu, Ihab Abdulkader, Josep Ramirez, Noemí Reguart, Marta Salido, Lara Pijuán, Edurne Arriola, Julián Sanz, Victoria Folgueras, Noemí Villanueva, Javier Gómez-Román, Manuel Hidalgo, Fernando López-Ríos. PLoS One 2014
Times Cited: 50







List of co-cited articles
576 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Eunice L Kwak, Yung-Jue Bang, D Ross Camidge, Alice T Shaw, Benjamin Solomon, Robert G Maki, Sai-Hong I Ou, Bruce J Dezube, Pasi A Jänne, Daniel B Costa,[...]. N Engl J Med 2010
54

Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances.
Florian Cabillic, Audrey Gros, Frédéric Dugay, Hugues Begueret, Laura Mesturoux, Dan Cristian Chiforeanu, Leila Dufrenot, Vincent Jauffret, Dominique Dachary, Romain Corre,[...]. J Thorac Oncol 2014
126
52

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
Manabu Soda, Young Lim Choi, Munehiro Enomoto, Shuji Takada, Yoshihiro Yamashita, Shunpei Ishikawa, Shin-ichiro Fujiwara, Hideki Watanabe, Kentaro Kurashina, Hisashi Hatanaka,[...]. Nature 2007
50

ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH.
Eugen C Minca, Bryce P Portier, Zhen Wang, Christopher Lanigan, Carol F Farver, Yan Feng, Patrick C Ma, Valeria A Arrossi, Nathan A Pennell, Raymond R Tubbs. J Mol Diagn 2013
92
48

Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Marina Pekar-Zlotin, Fred R Hirsch, Lior Soussan-Gutman, Maya Ilouze, Addie Dvir, Theresa Boyle, Murry Wynes, Vincent A Miller, Doron Lipson, Gary A Palmer,[...]. Oncologist 2015
109
46

Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas.
Lynette M Sholl, Stanislawa Weremowicz, Stacy W Gray, Kwok-Kin Wong, Lucian R Chirieac, Neal I Lindeman, Jason L Hornick. J Thorac Oncol 2013
115
44

Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.
Spasenija Savic, Joachim Diebold, Anne-Katrin Zimmermann, Wolfram Jochum, Betty Baschiera, Susanne Grieshaber, Luigi Tornillo, Bettina Bisig, Keith Kerr, Lukas Bubendorf. Lung Cancer 2015
59
44

ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.
Greta Alì, Agnese Proietti, Serena Pelliccioni, Cristina Niccoli, Cristiana Lupi, Elisa Sensi, Riccardo Giannini, Nicla Borrelli, Maura Menghi, Antonio Chella,[...]. Arch Pathol Lab Med 2014
70
40

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project.
Fiona H Blackhall, Solange Peters, Lukas Bubendorf, Urania Dafni, Keith M Kerr, Henrik Hager, Alex Soltermann, Kenneth J O'Byrne, Christoph Dooms, Aleksandra Sejda,[...]. J Clin Oncol 2014
118
40

Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent.
Chris M J Conklin, Kenneth J Craddock, Cherry Have, Janessa Laskin, Christian Couture, Diana N Ionescu. J Thorac Oncol 2013
152
38


An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators.
Murry W Wynes, Lynette M Sholl, Manfred Dietel, Ed Schuuring, Ming S Tsao, Yasushi Yatabe, Raymond R Tubbs, Fred R Hirsch. J Thorac Oncol 2014
116
36

Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH.
Eunhee S Yi, Jennifer M Boland, Joseph J Maleszewski, Anja C Roden, Andre M Oliveira, Marie-Christine Aubry, Michele R Erickson-Johnson, Bolette L Caron, Yan Li, Hui Tang,[...]. J Thorac Oncol 2011
219
34

Clinical Implications of Variant ALK FISH Rearrangement Patterns.
Xin Gao, Lynette M Sholl, Mizuki Nishino, Jennifer C Heng, Pasi A Jänne, Geoffrey R Oxnard. J Thorac Oncol 2015
38
44

Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: evaluation of five different ALK antibody clones and ALK FISH.
Georg Hutarew, Cornelia Hauser-Kronberger, Felix Strasser, Ida C Llenos, Otto Dietze. Histopathology 2014
46
34

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization.
Christina I Selinger, Toni-Maree Rogers, Prudence A Russell, Sandra O'Toole, Poyee Yip, Gavin M Wright, Zoe Wainer, Lisa G Horvath, Michael Boyer, Brian McCaughan,[...]. Mod Pathol 2013
115
32

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. Arch Pathol Lab Med 2013
310
30

Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer.
Jean-Claude Cutz, Kenneth J Craddock, Emina Torlakovic, Guilherme Brandao, Ronald F Carter, Gilbert Bigras, Jean Deschenes, Iyare Izevbaye, Zhaolin Xu, Wenda Greer,[...]. J Thorac Oncol 2014
60
30

A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.
Mari Mino-Kenudson, Lucian R Chirieac, Kenny Law, Jason L Hornick, Neal Lindeman, Eugene J Mark, David W Cohen, Bruce E Johnson, Pasi A Jänne, A John Iafrate,[...]. Clin Cancer Res 2010
336
30

ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas.
Lynette M Sholl, Heather Sun, Mohit Butaney, Chengsheng Zhang, Charles Lee, Pasi A Jänne, Scott J Rodig. Am J Surg Pathol 2013
111
30

Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study.
Anne McLeer-Florin, Denis Moro-Sibilot, Adrien Melis, Dimitri Salameire, Christine Lefebvre, Françoise Ceccaldi, Florence de Fraipont, Elisabeth Brambilla, Sylvie Lantuejoul. J Thorac Oncol 2012
157
30

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
Alice T Shaw, Beow Y Yeap, Mari Mino-Kenudson, Subba R Digumarthy, Daniel B Costa, Rebecca S Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott,[...]. J Clin Oncol 2009
28

Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancer.
Nir Peled, Gary Palmer, Fred R Hirsch, Murry W Wynes, Maya Ilouze, Marileila Varella-Garcia, Lior Soussan-Gutman, Geoff A Otto, Philip J Stephens, Jeffrey S Ross,[...]. J Thorac Oncol 2012
105
28

On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas.
Lénaïg Mescam-Mancini, Sylvie Lantuéjoul, Denis Moro-Sibilot, Isabelle Rouquette, Pierre-Jean Souquet, Clarisse Audigier-Valette, Jean-Christophe Sabourin, Chantal Decroisette, Linda Sakhri, Elisabeth Brambilla,[...]. Lung Cancer 2014
80
28


Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
Alice T Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De Pas, Benjamin Besse, Benjamin J Solomon, Fiona Blackhall,[...]. N Engl J Med 2013
28

ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.
Antonio Marchetti, Alessia Di Lorito, Maria Vittoria Pace, Manuela Iezzi, Lara Felicioni, Tommaso D'Antuono, Giampaolo Filice, Luigi Guetti, Felice Mucilli, Fiamma Buttitta. J Thorac Oncol 2016
89
28

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. J Thorac Oncol 2013
536
26

Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
Heae Surng Park, June Koo Lee, Dong-Wan Kim, Kimary Kulig, Tae Min Kim, Se-Hoon Lee, Yoon-Kyung Jeon, Doo Hyun Chung, Dae Seog Heo. Lung Cancer 2012
92
26

Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
Jin Ho Paik, Gheeyoung Choe, Hyojin Kim, Ji-Young Choe, Hyun Ju Lee, Choon-Taek Lee, Jong Seok Lee, Sanghoon Jheon, Jin-Haeng Chung. J Thorac Oncol 2011
223
26

Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers.
Akihiko Yoshida, Koji Tsuta, Susumu Wakai, Yasuhito Arai, Hisao Asamura, Tatsuhiro Shibata, Koh Furuta, Takashi Kohno, Ryoji Kushima. Mod Pathol 2014
87
26

ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision making.
Maximilian von Laffert, Albrecht Stenzinger, Michael Hummel, Wilko Weichert, Dido Lenze, Arne Warth, Roland Penzel, Hermann Herbst, Udo Kellner, Philipp Jurmeister,[...]. Lung Cancer 2015
33
39

Detection of ALK expression in non-small-cell lung cancer with ALK gene rearrangements--comparison of multiple immunohistochemical methods.
Karen Zwaenepoel, Amber Van Dongen, Suzan Lambin, Christine Weyn, Patrick Pauwels. Histopathology 2014
23
52

Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.
Maximilian von Laffert, Arne Warth, Roland Penzel, Peter Schirmacher, Keith M Kerr, Göran Elmberger, Hans-Ulrich Schildhaus, Reinhard Büttner, Fernando Lopez-Rios, Simone Reu,[...]. J Thorac Oncol 2014
54
24

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
Benjamin J Solomon, Tony Mok, Dong-Wan Kim, Yi-Long Wu, Kazuhiko Nakagawa, Tarek Mekhail, Enriqueta Felip, Federico Cappuzzo, Jolanda Paolini, Tiziana Usari,[...]. N Engl J Med 2014
24

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.
K M Kerr, L Bubendorf, M J Edelman, A Marchetti, T Mok, S Novello, K O'Byrne, R Stahel, S Peters, E Felip. Ann Oncol 2014
159
24

French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.
Sylvie Lantuejoul, Isabelle Rouquette, Hélène Blons, Nolwenn Le Stang, Marius Ilie, Hugues Begueret, Valerie Grégoire, Paul Hofman, Audrey Gros, Stephane Garcia,[...]. Eur Respir J 2015
44
27

Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment.
D Ross Camidge, Scott A Kono, Antonella Flacco, Aik-Choon Tan, Robert C Doebele, Qing Zhou, Lucio Crino, Wilbur A Franklin, Marileila Varella-Garcia. Clin Cancer Res 2010
260
22

Detection of ALK-positive non-small-cell lung cancers on cytological specimens: high accuracy of immunocytochemistry with the 5A4 clone.
Spasenija Savic, Beata Bode, Joachim Diebold, Ivo Tosoni, Audrey Barascud, Betty Baschiera, Bruno Grilli, Michelle Herzog, Ellen Obermann, Lukas Bubendorf. J Thorac Oncol 2013
72
22

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations.
Erik Thunnissen, Lukas Bubendorf, Manfred Dietel, Göran Elmberger, Keith Kerr, Fernando Lopez-Rios, Holger Moch, Wlodzimierz Olszewski, Patrick Pauwels, Frédérique Penault-Llorca,[...]. Virchows Arch 2012
153
22

Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
Hyojin Kim, Seol-Bong Yoo, Ji-Young Choe, Jin Ho Paik, Xianhua Xu, Hiroaki Nitta, Wenjun Zhang, Thomas M Grogan, Choon-Taek Lee, Sanghoon Jheon,[...]. J Thorac Oncol 2011
122
22

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.
Alice T Shaw, Beow Y Yeap, Benjamin J Solomon, Gregory J Riely, Justin Gainor, Jeffrey A Engelman, Geoffrey I Shapiro, Daniel B Costa, Sai-Hong I Ou, Mohit Butaney,[...]. Lancet Oncol 2011
668
22

Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.
Scott J Rodig, Mari Mino-Kenudson, Sanja Dacic, Beow Y Yeap, Alice Shaw, Justine A Barletta, Hannah Stubbs, Kenny Law, Neal Lindeman, Eugene Mark,[...]. Clin Cancer Res 2009
476
22


ROS1 immunohistochemistry among major genotypes of non-small-cell lung cancer.
Theresa A Boyle, Katsuhiro Masago, Kim E Ellison, Yasushi Yatabe, Fred R Hirsch. Clin Lung Cancer 2015
37
27

KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.
Kengo Takeuchi, Young Lim Choi, Yuki Togashi, Manabu Soda, Satoko Hatano, Kentaro Inamura, Shuji Takada, Toshihide Ueno, Yoshihiro Yamashita, Yukitoshi Satoh,[...]. Clin Cancer Res 2009
513
20

Testing for ROS1 in non-small cell lung cancer: a review with recommendations.
Lukas Bubendorf, Reinhard Büttner, Fouad Al-Dayel, Manfred Dietel, Göran Elmberger, Keith Kerr, Fernando López-Ríos, Antonio Marchetti, Büge Öz, Patrick Pauwels,[...]. Virchows Arch 2016
112
20

Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements.
Yoon Jin Cha, Jae Seok Lee, Hye Ryun Kim, Sun Min Lim, Byoung Chul Cho, Chang Young Lee, Hyo Sup Shim. PLoS One 2014
57
18

Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Alice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, D Ross Camidge, Benjamin J Solomon, Ravi Salgia, Gregory J Riely, Marileila Varella-Garcia, Geoffrey I Shapiro, Daniel B Costa,[...]. N Engl J Med 2014
18

Atypical negative ALK break-apart FISH harboring a crizotinib-responsive ALK rearrangement in non-small-cell lung cancer.
Shengxiang Ren, Fred R Hirsch, Marileila Varella-Garcia, Dara L Aisner, Theresa Boyle, Caicun Zhou, D Ross Camidge. J Thorac Oncol 2014
50
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.